Dobutamine shortage status
1 active shortage notice across 1 country.
Last updated 26 May 2026 · sourced from official medicines regulators
- Generic name (INN)
- Dobutamine
- Brand names
- Dobutamina Generis, Dobutamine Panpharma, Dobutamine In Dextrose
- ATC code
- C01CA07
- Class
- Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Where Dobutamine is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | high | 1 | 28 May 2025 | — | FDA MedWatch |
Why Dobutamine is in shortage
- regulatory action — e.g. “Discoloration; discolored solution from cracked vials” (United States)
Frequently asked questions
Is Dobutamine currently in shortage?
Yes. As of the latest regulator updates, Dobutamine has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Dobutamine in shortage?
Regulators attribute the current Dobutamine shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Dobutamine shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Dopamine Hydrochloride · Noradrenaline · Dobutamine (Chlorhydrate De) · Dopamine Hcl (2014 · Angiotensin Ii · Dobutamina
Get alerted when Dobutamine status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.